L-159-2021
Agreement ID
L-159-2021
Lead IC
NCI
Exclusivity
Exclusive
External Party
Kyverna Therapeutics, Inc.
Fiscal Year
2021
Territory
Worldwide
Execution Date
Effective Date
Export Date
Technologies